OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges and Opportunities
Miguel Vaz, Vítor Silva, Cristina Monteiro, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 797-810
Open Access | Times Cited: 117

Showing 26-50 of 117 citing articles:

Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access

Implications of Microorganisms in Alzheimer’s Disease
Pardeep Yadav, Yeon‐Hee Lee, Hrithika Panday, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 10, pp. 4584-4615
Open Access | Times Cited: 19

Synthesis and Biological Evaluation of Coumarin Triazoles as Dual Inhibitors of Cholinesterases and β-Secretase
Ankita Sharma, Sandip B. Bharate
ACS Omega (2023) Vol. 8, Iss. 12, pp. 11161-11176
Open Access | Times Cited: 12

The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment
Emily Knight, Thangiah Geetha, Tom L. Broderick, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 438-438
Open Access | Times Cited: 12

Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice
Philippos Koulousakis, Emily Willems, Melissa Schepers, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 3, pp. 1207-1219
Open Access | Times Cited: 11

Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics
Brati Chakraborty, Gayatri Patel, Bandana Padhan, et al.
Applied Materials Today (2024) Vol. 41, pp. 102442-102442
Closed Access | Times Cited: 4

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 4

Alzheimer’s Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery
Jose Dominguez-Gortaire, Alejandra Ruiz, Ana B. Porto-Pazos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1004-1004
Open Access

Integrating NLP and LLMs to discover biomarkers and mechanisms in Alzheimer's disease
Jin‐Won Song, Junjie Huang, Richen Liu
SLAS TECHNOLOGY (2025), pp. 100257-100257
Open Access

CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access

Evaluation of the Sporadic Anti-Alzheimer’s Activity of Purpurin Using In Silico, In Vitro, and In Vivo Approaches
Kajol Rustage, Nitish Rai, Saurabh K. Sinha, et al.
Molecular Neurobiology (2025)
Closed Access

Co-Deposited Proteins in Alzheimer’s Disease as a Potential Treasure Trove for Drug Repurposing
Avgi E. Apostolakou, Dimitra E. Douska, Zoi I. Litou, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1736-1736
Open Access

Anticorps monoclonaux anti-amyloïde Beta contre la maladie d’Alzheimer en 2025 : prudence ou scepticisme ?
G Bouvenot
Bulletin de l Académie Nationale de Médecine (2025)
Closed Access

Experimental approaches for altering the expression of Abeta‐degrading enzymes
David A. Loeffler
Journal of Neurochemistry (2023) Vol. 164, Iss. 6, pp. 725-763
Open Access | Times Cited: 9

Current trends and updates in the treatment of Alzheimer's disease
Nisha I. Parikh, Palak K. Parikh, Hetansh J. Rao, et al.
Elsevier eBooks (2024), pp. 373-390
Closed Access | Times Cited: 3

Digital Health Technologies for Alzheimer’s Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort
S Lott, Emmanuel Streel, Shelby L. Bachman, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Closed Access | Times Cited: 3

Research Progress on the Pathogenesis, Diagnosis, and Drug Therapy of Alzheimer’s Disease
Yixuan Yang, Lina Qiu
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 590-590
Open Access | Times Cited: 3

Potential implications of polyphenolic compounds in neurodegenerative diseases
Ruidie Shi, Daili Gao, Rostyslav Stoika, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 16, pp. 5491-5514
Closed Access | Times Cited: 14

Piperidine Nucleus as a Promising Scaffold for Alzheimer’s Disease: Current Landscape and Future Perspective
Parul Grover, Suman Rohilla, Monika Bhardwaj, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1221-1259
Closed Access | Times Cited: 7

Atypical instantaneous spatio-temporal patterns of neural dynamics in Alzheimer’s disease
Sou Nobukawa, Takashi Ikeda, Mitsuru Kikuchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Detecting Selected Neurodegenerative Diseases Through Microwave Technology: Modeling and Identifying Different Stages of Alzheimer's Disease
M. Abdel-Aleim M., Mohamed Hassan, Fathy Abo Sree Mohamed
2022 4th International Youth Conference on Radio Electronics, Electrical and Power Engineering (REEPE) (2024), pp. 1-6
Closed Access | Times Cited: 2

Functional aspects of the brain lymphatic drainage system in aging and neurodegenerative diseases
Yan Chen, Xiaoxin He, Jiachen Cai, et al.
Journal of Biomedical Research (2024) Vol. 38, Iss. 3, pp. 206-206
Open Access | Times Cited: 2

Scroll to top